Difference between revisions of "Pilot Conformance Projects Under Development"

From QIBA Wiki
Jump to: navigation, search
m
Line 15: Line 15:
 
Before starting conformance testing, please [mailto:qiba@rsna.org Email QIBA]
 
Before starting conformance testing, please [mailto:qiba@rsna.org Email QIBA]
  
== <font color=green>'''QIBA Profiles that are available for self-attestation conformance testing:'''</font> ==
+
== <font color=green>'''Self Attestation of Conformance'''</font> ==
  
==CT: Lung Tumor Volume (Advanced Disease)==
+
The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.
 +
 
 +
===CT: Lung Tumor Volume (Advanced Disease)===
 
*'''Profile'''
 
*'''Profile'''
 
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]]
 
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]]
Line 26: Line 28:
 
*'''Report Template'''
 
*'''Report Template'''
  
==FDG-PET: Solid Tumor SUV==
+
===FDG-PET: Solid Tumor SUV===
 
*'''Profile'''
 
*'''Profile'''
 
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]]
 
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]]
Line 33: Line 35:
 
*'''Report Template'''
 
*'''Report Template'''
  
==MR: ADC-DW MR Lesions in Four Organs==
+
===MR: ADC-DW MR Lesions in Four Organs===
 
*'''Profile'''
 
*'''Profile'''
 
*[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]]
 
*[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]]
Line 43: Line 45:
  
  
== <font color=purple>'''QIBA Profiles that are available for QIBA or designee testing:'''</font> ==
+
== <font color=purple>'''QIBA or Designee Testing of Conformance'''</font> ==
 +
 
 +
===CT Small Lung Nodule Volumetry for Screening===
 +
 
 
*[[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-2.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]]
 
*[[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-2.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]]
 
*https://www.rsna.org/en/research/quantitative-imaging-biomarkers-alliance/qiba-conformance-certification-services
 
*https://www.rsna.org/en/research/quantitative-imaging-biomarkers-alliance/qiba-conformance-certification-services

Revision as of 21:41, 18 November 2019


QIBA Profile Conformance

{This content will eventually be available on the RSNA.org website.}

QIBA Profiles that are at least at consensus level (link to wiki page on development of a Profile) are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile. There are two different ways to show QIBA Profile conformance:

  • Self – attestation
  • Certification service

The basic process flow is shown below:

Profile Conformance Image.jpg

Before starting conformance testing, please Email QIBA

Self Attestation of Conformance

The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.

CT: Lung Tumor Volume (Advanced Disease)

  • Report Template

FDG-PET: Solid Tumor SUV

MR: ADC-DW MR Lesions in Four Organs


QIBA or Designee Testing of Conformance

CT Small Lung Nodule Volumetry for Screening